Tablet
Generics: Saroglitazar Magnesium
Brand: Beacon Pharmaceuticals Ltd.
Sarozar tablet is indicated for the treatment of diabetic dyslipidemia and hypertriglyceridemia with Type 2 diabetes mellitus not controlled by statin therapy. In clinical studies, Sarozar tablet has demonstrated reduction of triglycerides (TG), Low Density Lipoprotein (LDL) cholesterol, Very Low Density Lipoprotein (VLDL) cholesterol, non-High Density Lipoprotein (non- HDL) cholesterol and an increase in HDL cholesterol. It has also shown favorable glycemic indices by reducing the fasting plasma glucose and glycosylated hemoglobin in diabetic patients.
Your purchase will delivered in 1 shipment
Your shopping bag is empty. Start shopping now.